COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
1847 GOEDEKER INC | *W EXP 99/99/999 | 28252C117 | 14,737 | 6,886,600 | SH | | SOLE | | 6,886,600 | 0 | 0 |
ACE CONVERGENCE ACQU CORP | CL A | G0083D120 | 483 | 48,530 | SH | | SOLE | | 48,530 | 0 | 0 |
ACHIEVE LIFE SCIENCES INC | COM | 004468500 | 1,096 | 122,000 | SH | | SOLE | | 122,000 | 0 | 0 |
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 2,487 | 470,949 | SH | | SOLE | | 470,949 | 0 | 0 |
ADICET BIO INC | COM | 007002108 | 1,464 | 142,289 | SH | | SOLE | | 142,289 | 0 | 0 |
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 4,243 | 609,689 | SH | | SOLE | | 609,689 | 0 | 0 |
AJAX I | COM | G0190X100 | 1,245 | 125,000 | SH | | SOLE | | 125,000 | 0 | 0 |
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 9,789 | 864,020 | SH | | SOLE | | 864,020 | 0 | 0 |
ALPHA HEALTHCARE ACQUISTN CO | CL A | 020751103 | 2,802 | 275,000 | SH | | SOLE | | 275,000 | 0 | 0 |
ALPHA HEALTHCARE ACQUISTN CO | *W EXP 09/21/202 | 020751111 | 385 | 137,500 | SH | | SOLE | | 137,500 | 0 | 0 |
ALPHA TEKNOVA INC | COM | 02080L102 | 593 | 25,000 | SH | | SOLE | | 25,000 | 0 | 0 |
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 6,313 | 231,314 | SH | | SOLE | | 231,314 | 0 | 0 |
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 1,072 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 4,263 | 328,908 | SH | | SOLE | | 328,908 | 0 | 0 |
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 2,965 | 440,589 | SH | | SOLE | | 440,589 | 0 | 0 |
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 4,660 | 188,600 | SH | | SOLE | | 188,600 | 0 | 0 |
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 1,053 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 5,563 | 1,788,789 | SH | | SOLE | | 1,788,789 | 0 | 0 |
BETTER CHOICE CO INC | COM | 08771Y303 | 86 | 20,000 | SH | | SOLE | | 20,000 | 0 | 0 |
BRIACELL THERAPEUTICS CORP | COM NEW | 10778Y302 | 4,266 | 800,295 | SH | | SOLE | | 800,295 | 0 | 0 |
BRIACELL THERAPEUTICS CORP | *W EXP 02/24/202 | 10778Y112 | 377 | 209,540 | SH | | SOLE | | 209,540 | 0 | 0 |
CARA THERAPEUTICS INC | COM | 140755109 | 2,141 | 150,000 | SH | | SOLE | | 150,000 | 0 | 0 |
CARDIFF ONCOLOGY INC | COM | 14147L108 | 3,337 | 501,878 | SH | | SOLE | | 501,878 | 0 | 0 |
CAREDX INC | COM | 14167L103 | 5,805 | 63,434 | SH | | SOLE | | 63,434 | 0 | 0 |
CASTLE BIOSCIENCES INC | COM | 14843C105 | 5,060 | 69,000 | SH | | SOLE | | 69,000 | 0 | 0 |
CELCUITY INC | COM | 15102K100 | 3,480 | 145,000 | SH | | SOLE | | 145,000 | 0 | 0 |
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 3,114 | 93,116 | SH | | SOLE | | 93,116 | 0 | 0 |
CERUS CORP | COM | 157085101 | 4,813 | 814,328 | SH | | SOLE | | 814,328 | 0 | 0 |
CHARDAN HEALTHCR ACQSTN 2 CO | *W EXP 03/05/202 | 15957T115 | 469 | 731,561 | SH | | SOLE | | 731,561 | 0 | 0 |
CHARDAN HEALTHCR ACQSTN 2 CO | COM | 15957T107 | 7,509 | 753,874 | SH | | SOLE | | 753,874 | 0 | 0 |
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 5,882 | 416,567 | SH | | SOLE | | 416,567 | 0 | 0 |
CITIC CAPITAL ACQUISITION CO | COM CL A | G21513109 | 1,102 | 111,200 | SH | | SOLE | | 111,200 | 0 | 0 |
COCRYSTAL PHARMA INC | COM | 19188J300 | 970 | 776,000 | SH | | SOLE | | 776,000 | 0 | 0 |
COLISEUM ACQUISITION CORP | UNIT 04/02/2028 | G2263T115 | 840 | 85,000 | SH | | SOLE | | 85,000 | 0 | 0 |
COLOMBIER ACQUISITION CORP | UNIT 99/99/9999 | 19533H207 | 496 | 50,000 | SH | | SOLE | | 50,000 | 0 | 0 |
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 10,048 | 533,033 | SH | | SOLE | | 533,033 | 0 | 0 |
CTI BIOPHARMA CORP | COM | 12648L601 | 9,197 | 3,678,677 | SH | | SOLE | | 3,678,677 | 0 | 0 |
CURIS INC | COM NEW | 231269200 | 6,690 | 829,000 | SH | | SOLE | | 829,000 | 0 | 0 |
CVRX INC | COM | 126638105 | 1,680 | 60,000 | SH | | SOLE | | 60,000 | 0 | 0 |
CYTOKINETICS INC | COM NEW | 23282W605 | 1,668 | 84,262 | SH | | SOLE | | 84,262 | 0 | 0 |
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 5,459 | 862,417 | SH | | SOLE | | 862,417 | 0 | 0 |
DYNE THERAPEUTICS INC | COM | 26818M108 | 3,506 | 166,636 | SH | | SOLE | | 166,636 | 0 | 0 |
EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 1,683 | 197,500 | SH | | SOLE | | 197,500 | 0 | 0 |
ELECTROCORE INC | COM | 28531P103 | 5,950 | 5,000,000 | SH | | SOLE | | 5,000,000 | 0 | 0 |
ELOXX PHARMACEUTICALS INC | COM | 29014R103 | 1,334 | 670,118 | SH | | SOLE | | 670,118 | 0 | 0 |
ESSA PHARMA INC | COM NEW | 29668H708 | 6,100 | 213,528 | SH | | SOLE | | 213,528 | 0 | 0 |
EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 139 | 133,333 | SH | | SOLE | | 133,333 | 0 | 0 |
EUCRATES BIOMEDICAL ACQU COR | SHS | G3141W106 | 3,938 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 3,331 | 370,551 | SH | | SOLE | | 370,551 | 0 | 0 |
FAT BRANDS INC | *W EXP 07/16/202 | 30258N121 | 2,229 | 233,697 | SH | | SOLE | | 233,697 | 0 | 0 |
FIRSTMARK HORIZON ACQUISITIO | CL A COM | 33765Y101 | 993 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
FS DEVELOPMENT CORP II | COM CL A | 30318F100 | 1,996 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
FULCRUM THERAPEUTICS INC | COM | 359616109 | 2,238 | 213,533 | SH | | SOLE | | 213,533 | 0 | 0 |
GALERA THERAPEUTICS INC | COM | 36338D108 | 2,162 | 219,900 | SH | | SOLE | | 219,900 | 0 | 0 |
GIGINTERNATIONAL1 INC | UNIT 05/19/2026 | 37518W205 | 2,008 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
GLAUKOS CORP | COM | 377322102 | 3,427 | 40,400 | SH | | SOLE | | 40,400 | 0 | 0 |
GLOBUS MED INC | CL A | 379577208 | 5,492 | 70,833 | SH | | SOLE | | 70,833 | 0 | 0 |
HAEMONETICS CORP MASS | COM | 405024100 | 3,532 | 53,000 | SH | | SOLE | | 53,000 | 0 | 0 |
HARBOR CUSTOM DEVELOPMENT IN | *W EXP 05/09/202 | 41150T116 | 378 | 600,000 | SH | | SOLE | | 600,000 | 0 | 0 |
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 102 | 10,000 | SH | | SOLE | | 10,000 | 0 | 0 |
HEALTHCOR CATALIO ACQU CORP | CL A SHS | G44125105 | 1,970 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 2,588 | 250,000 | SH | | SOLE | | 250,000 | 0 | 0 |
HEPION PHARMACEUTICALS INC | COM | 426897104 | 883 | 446,000 | SH | | SOLE | | 446,000 | 0 | 0 |
IGM BIOSCIENCES INC | COM | 449585108 | 3,534 | 42,473 | SH | | SOLE | | 42,473 | 0 | 0 |
ILLUMINA INC | COM | 452327109 | 3,786 | 8,000 | SH | | SOLE | | 8,000 | 0 | 0 |
IM CANNABIS CORP | COM NEW | 44969Q208 | 1,709 | 321,845 | SH | | SOLE | | 321,845 | 0 | 0 |
IMMATICS N.V | SHS | N44445109 | 4,000 | 344,558 | SH | | SOLE | | 344,558 | 0 | 0 |
IMMATICS N.V | *W EXP 07/01/202 | N44445117 | 335 | 97,467 | SH | | SOLE | | 97,467 | 0 | 0 |
IMMUNOVANT INC | COM | 45258J102 | 3,541 | 335,041 | SH | | SOLE | | 335,041 | 0 | 0 |
INFINITY PHARMACEUTICALS INC | COM | 45665G303 | 2,794 | 934,327 | SH | | SOLE | | 934,327 | 0 | 0 |
INFLARX NV | COM | N44821101 | 479 | 161,206 | SH | | SOLE | | 161,206 | 0 | 0 |
INHIBIKASE THERAPEUTICS INC | COM | 45719W106 | 307 | 109,749 | SH | | SOLE | | 109,749 | 0 | 0 |
INMUNE BIO INC | COM | 45782T105 | 918 | 52,257 | SH | | SOLE | | 52,257 | 0 | 0 |
INSMED INC | COM PAR $.01 | 457669307 | 5,787 | 203,354 | SH | | SOLE | | 203,354 | 0 | 0 |
INSPIRE MED SYS INC | COM | 457730109 | 3,992 | 20,655 | SH | | SOLE | | 20,655 | 0 | 0 |
INSULET CORP | COM | 45784P101 | 4,667 | 17,000 | SH | | SOLE | | 17,000 | 0 | 0 |
INTERSECT ENT INC | COM | 46071F103 | 3,118 | 182,456 | SH | | SOLE | | 182,456 | 0 | 0 |
IRHYTHM TECHNOLOGIES INC | COM | 450056106 | 1,009 | 15,206 | SH | | SOLE | | 15,206 | 0 | 0 |
IVERIC BIO INC | COM | 46583P102 | 5,696 | 902,633 | SH | | SOLE | | 902,633 | 0 | 0 |
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 1,988 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
KALEYRA INC | COM | 483379103 | 7,834 | 640,000 | SH | | SOLE | | 640,000 | 0 | 0 |
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 2,680 | 111,834 | SH | | SOLE | | 111,834 | 0 | 0 |
KIROMIC BIOPHARMA INC | COM | 497634105 | 1,604 | 333,475 | SH | | SOLE | | 333,475 | 0 | 0 |
LAKESHORE ACQUISITION I CORP | UNIT 06/04/2026 | G53521129 | 2,044 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
LANTHEUS HLDGS INC | COM | 516544103 | 6,635 | 240,066 | SH | | SOLE | | 240,066 | 0 | 0 |
LIFESCI ACQUISITION II CORP | COM | 53229E103 | 2,500 | 250,000 | SH | | SOLE | | 250,000 | 0 | 0 |
MEI PHARMA INC | COM NEW | 55279B202 | 5,210 | 1,828,066 | SH | | SOLE | | 1,828,066 | 0 | 0 |
MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 3,963 | 1,250,000 | SH | | SOLE | | 1,250,000 | 0 | 0 |
MORPHIC HLDG INC | COM | 61775R105 | 2,327 | 40,541 | SH | | SOLE | | 40,541 | 0 | 0 |
MOTIVE CAPITAL CORP | SHS CL A | G6293A103 | 998 | 102,099 | SH | | SOLE | | 102,099 | 0 | 0 |
MYRIAD GENETICS INC | COM | 62855J104 | 5,237 | 171,242 | SH | | SOLE | | 171,242 | 0 | 0 |
NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 3,531 | 54,500 | SH | | SOLE | | 54,500 | 0 | 0 |
NATERA INC | COM | 632307104 | 3,773 | 33,230 | SH | | SOLE | | 33,230 | 0 | 0 |
NEURONETICS INC | COM | 64131A105 | 2,957 | 184,554 | SH | | SOLE | | 184,554 | 0 | 0 |
NEVRO CORP | COM | 64157F103 | 4,460 | 26,900 | SH | | SOLE | | 26,900 | 0 | 0 |
NOCTURNE ACQUISITION CORP | ORDINARY SHARES | G6580S114 | 4,930 | 500,000 | SH | | SOLE | | 500,000 | 0 | 0 |
NOCTURNE ACQUISITION CORP | RIGHT 12/26/2025 | G6580S106 | 190 | 500,000 | SH | | SOLE | | 500,000 | 0 | 0 |
OCULAR THERAPEUTIX INC | COM | 67576A100 | 3,632 | 256,152 | SH | | SOLE | | 256,152 | 0 | 0 |
OMEGA ALPHA SPAC | CL A | G6749V107 | 995 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
ONCTERNAL THERAPEUTICS INC | COM | 68236P107 | 818 | 172,218 | SH | | SOLE | | 172,218 | 0 | 0 |
PALISADE BIO INC | COM | 696389105 | 7,427 | 1,824,894 | SH | | SOLE | | 1,824,894 | 0 | 0 |
PHASEBIO PHARMACEUTICALS INC | COM | 717224109 | 2,883 | 775,000 | SH | | SOLE | | 775,000 | 0 | 0 |
PORTAGE BIOTECH INC | COM | G7185A128 | 1,572 | 75,000 | SH | | SOLE | | 75,000 | 0 | 0 |
PROFOUND MED CORP | COM NEW | 74319B502 | 3,440 | 210,280 | SH | | SOLE | | 210,280 | 0 | 0 |
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 12,676 | 282,445 | SH | | SOLE | | 282,445 | 0 | 0 |
PURECYCLE TECHNOLOGIES INC | *W EXP 01/28/202 | 74623V111 | 1,599 | 130,875 | SH | | SOLE | | 130,875 | 0 | 0 |
QELL ACQUISITION CORP | CL A | G7307X105 | 995 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
RED CAT HLDGS INC | COM | 75644T100 | 266 | 102,290 | SH | | SOLE | | 102,290 | 0 | 0 |
REGENXBIO INC | COM | 75901B107 | 2,421 | 62,317 | SH | | SOLE | | 62,317 | 0 | 0 |
REPRO MED SYS INC | COM | 759910102 | 3,373 | 728,487 | SH | | SOLE | | 728,487 | 0 | 0 |
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 2,053 | 104,840 | SH | | SOLE | | 104,840 | 0 | 0 |
SARISSA CAPITAL ACQUISITN CO | UNIT 10/23/2027 | G7823W128 | 2,345 | 225,000 | SH | | SOLE | | 225,000 | 0 | 0 |
SECOND SIGHT MED PRODS INC | COM NEW | 81362J209 | 1,847 | 373,867 | SH | | SOLE | | 373,867 | 0 | 0 |
SERES THERAPEUTICS INC | COM | 81750R102 | 2,495 | 104,626 | SH | | SOLE | | 104,626 | 0 | 0 |
SIENTRA INC | COM | 82621J105 | 4,821 | 605,691 | SH | | SOLE | | 605,691 | 0 | 0 |
SUPERNOVA PARTNERS ACQUISITI | COM CL A | 86846V108 | 993 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
SURGALIGN HOLDINGS INC | COM | 86882C105 | 2,417 | 1,739,131 | SH | | SOLE | | 1,739,131 | 0 | 0 |
SYNCHRONOSS TECHNOLOGIES INC | COM | 87157B103 | 117 | 32,500 | SH | | SOLE | | 32,500 | 0 | 0 |
SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 5,869 | 1,076,942 | SH | | SOLE | | 1,076,942 | 0 | 0 |
TAILWIND ACQUISITION CORP | COM CL A | 87403Q102 | 1,280 | 128,414 | SH | | SOLE | | 128,414 | 0 | 0 |
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 2,045 | 70,573 | SH | | SOLE | | 70,573 | 0 | 0 |
TCR2 THERAPEUTICS INC | COM | 87808K106 | 3,432 | 209,130 | SH | | SOLE | | 209,130 | 0 | 0 |
THERAVANCE BIOPHARMA INC | COM | G8807B106 | 3,194 | 220,000 | SH | | SOLE | | 220,000 | 0 | 0 |
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 2,487 | 170,484 | SH | | SOLE | | 170,484 | 0 | 0 |
TURMERIC ACQUISITION CORP | CL A | G9127T108 | 2,512 | 254,000 | SH | | SOLE | | 254,000 | 0 | 0 |
TURMERIC ACQUISITION CORP | *W EXP 10/08/202 | G9127T124 | 78 | 84,666 | SH | | SOLE | | 84,666 | 0 | 0 |
UPHEALTH INC | *W EXP 06/08/202 | 91532B119 | 9 | 10,000 | SH | | SOLE | | 10,000 | 0 | 0 |
VALLON PHARMACEUTICALS INC | COM | 92023M101 | 878 | 161,440 | SH | | SOLE | | 161,440 | 0 | 0 |
VAREX IMAGING CORP | COM | 92214X106 | 3,790 | 141,319 | SH | | SOLE | | 141,319 | 0 | 0 |
VERASTEM INC | COM | 92337C104 | 6,982 | 1,715,589 | SH | | SOLE | | 1,715,589 | 0 | 0 |
VERRICA PHARMACEUTICALS INC | COM | 92511W108 | 5,934 | 525,127 | SH | | SOLE | | 525,127 | 0 | 0 |
VINCERX PHARMA INC | COM NEW | 92731L106 | 1,398 | 107,625 | SH | | SOLE | | 107,625 | 0 | 0 |
XENON PHARMACEUTICALS INC | COM | 98420N105 | 2,886 | 155,000 | SH | | SOLE | | 155,000 | 0 | 0 |
XTANT MED HLDGS INC | COM NEW | 98420P308 | 13,517 | 8,292,602 | SH | | SOLE | | 8,292,602 | 0 | 0 |
YUMANITY THERAPEUTICS INC | COM | 98872L102 | 1,441 | 123,693 | SH | | SOLE | | 123,693 | 0 | 0 |